Wright Richard J, Stringer Jeffrey S A
Tufts University School of Medicine (Wright), Boston, Massachusetts, USA.
Am J Prev Med. 2004 Jul;27(1):42-8. doi: 10.1016/j.amepre.2004.03.004.
Nearly 30 million people in sub-Saharan Africa are infected with HIV. While recent commitment of resources from international donors is heartening, rational use of these resources for AIDS prevention and care will require a major scaling up of HIV diagnostic services in affected countries.
This paper considers the various settings and populations in which HIV testing might be implemented, and the goals to be achieved by that testing. It also defines the practical information that public health decision makers in sub-Saharan Africa should have in order to choose an appropriate test or combination of tests for use in a particular clinical setting.
Using a conditional probability model and published performance characteristics of rapid HIV serologic tests, the clinical effectiveness and costs of three major testing strategies are evaluated: (1) a single, highly sensitive test; (2) a serial algorithm, where positive results on a first test are confirmed with a more specific second test; and (3) a parallel algorithm, where each specimen is tested with two separate rapid tests, and discordant results are resolved with a third, different rapid test. This analysis was performed in 2003.
We suggest that in any setting, both a serial and a parallel algorithm yield fewer incorrect results than does a single screening assay, but are more costly. A parallel testing algorithm yields fewer incorrect results than does a serial algorithm, but is more costly.
We suggest that while a parallel testing algorithm has the advantage of avoiding indeterminate results, that strategy may be prohibitively costly for many developing world settings. Furthermore, we suggest that different testing algorithms are appropriate for different clinical settings.
撒哈拉以南非洲地区近3000万人感染了艾滋病毒。尽管国际捐助者最近承诺提供资源,这令人鼓舞,但要合理利用这些资源进行艾滋病预防和护理,就需要在受影响国家大幅扩大艾滋病毒诊断服务。
本文考虑了可能开展艾滋病毒检测的各种环境和人群,以及该检测要实现的目标。它还确定了撒哈拉以南非洲地区公共卫生决策者为在特定临床环境中选择合适的检测方法或检测组合而应掌握的实用信息。
使用条件概率模型和已发表的快速艾滋病毒血清学检测的性能特征,评估三种主要检测策略的临床有效性和成本:(1)单一的高灵敏度检测;(2)串联算法,即先用一种检测方法得出阳性结果后,再用更具特异性的第二种检测方法进行确认;(3)并联算法,即对每个样本用两种不同的快速检测方法进行检测,不一致的结果用第三种不同的快速检测方法解决。该分析于2003年进行。
我们认为,在任何情况下,串联算法和并联算法产生的错误结果都比单一筛查检测少,但成本更高。并联检测算法产生的错误结果比串联算法少,但成本更高。
我们认为,虽然并联检测算法具有避免不确定结果的优势,但对于许多发展中世界的环境来说,该策略的成本可能过高。此外,我们认为不同的检测算法适用于不同的临床环境。